Division of Outcomes Research, Department of Population Sciences, City of Hope Comprehensive Cancer Center, Duarte, CA, 91010, USA.
Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL, 35233, United States.
BMC Cancer. 2023 May 1;23(1):390. doi: 10.1186/s12885-023-10884-5.
BACKGROUND: Patients undergoing hematopoietic cell transplantation (HCT) are at high risk of chronic health complications, including frailty and physical dysfunction. Conventional exercise programs have been shown to improve frailty in other cancer populations, but these have largely been based out of rehabilitation facilities that may act as geographic and logistical barriers. There is a paucity of information on the feasibility of implementing telehealth exercise interventions in long-term HCT survivors. METHODS: We conducted a pilot randomized trial to assess the feasibility of an 8-week telehealth exercise intervention in 20 pre-frail or frail HCT survivors. Participants were randomized to either a telehealth exercise (N = 10) or delayed control (N = 10). We administered a remote physical function assessment at baseline, followed by an 8-week telehealth exercise intervention (30-60 min/session, 3 sessions/week), and post-intervention. The primary endpoint was feasibility as determined by 1) > 70% of participants completing all remote physical functional assessments, and 2) > 70% of participants in the exercise group completing > 70% (17/24) of the prescribed exercise sessions. Exploratory outcomes included changes in gait speed, handgrip strength, and short physical performance battery. RESULTS: The mean [standard deviation] age at study enrollment was 64.7 [9.1] years old. Twelve had undergone allogenic and 8 had undergone autologous HCT at an average of 17 years from study enrollment. Both feasibility criteria were achieved. Nineteen patients (95%) completed all remote study outcome assessments at baseline and post-intervention, and nine participants in the exercise group completed > 70% of prescribed exercise sessions. Overall, no significant group x time interaction was observed on handgrip strength, fatigue, body mass index, and short physical performance battery test (P < 0.05). However, there were significant within-group improvements in four-meter gait speed (+ 13.9%; P = 0.004) and 5-minute gait speed (+ 25.4%; P = 0.04) in the exercise group whereas non-significant changes in four-meter gait speed (-3.8%) and 5-minute gait speed (-5.8%) were observed after 8 weeks. CONCLUSION: Implementing an 8-week telehealth exercise intervention for long-term HCT survivors was feasible. Our findings set the stage for innovative delivery of supervised exercise intervention that reduces the burden of frailty in HCT survivors as well as other at-risk cancer survivors. TRIAL REGISTRATION: The protocol and informed consent were approved by the institutional IRB (IRB#20731) and registered (ClinicalTrials.gov NCT04968119; date of registration: 20/07/2021).
背景:接受造血细胞移植(HCT)的患者存在慢性健康并发症的高风险,包括虚弱和身体功能障碍。常规运动方案已被证明可改善其他癌症患者的虚弱,但这些方案主要基于康复设施,这可能成为地理和后勤方面的障碍。关于在长期 HCT 幸存者中实施远程医疗运动干预的可行性信息很少。
方法:我们进行了一项试点随机试验,以评估 20 名虚弱或脆弱的 HCT 幸存者进行 8 周远程医疗运动干预的可行性。参与者被随机分配到远程医疗运动组(N=10)或延迟对照组(N=10)。我们在基线时进行了远程身体功能评估,然后进行了 8 周的远程医疗运动干预(30-60 分钟/次,每周 3 次),并在干预后进行了评估。主要终点是通过以下两个标准来确定可行性:1)>70%的参与者完成所有远程身体功能评估,2)运动组中>70%(17/24)的参与者完成了>70%(17/24)的规定运动次数。探索性结果包括步态速度、握力和短程体能测试的变化。
结果:研究入组时的平均[标准差]年龄为 64.7[9.1]岁。12 人接受过同种异体移植,8 人接受过自体移植,从研究入组到现在平均 17 年。两个可行性标准都达到了。19 名患者(95%)在基线和干预后完成了所有远程研究结果评估,运动组的 9 名参与者完成了>70%的规定运动次数。总体而言,在握力、疲劳、体重指数和短程体能测试(P<0.05)方面,组间无显著交互作用。然而,运动组的 4 米步行速度(+13.9%;P=0.004)和 5 分钟步行速度(+25.4%;P=0.04)均有显著的组内改善,而 8 周后 4 米步行速度(-3.8%)和 5 分钟步行速度(-5.8%)无显著变化。
结论:为长期 HCT 幸存者实施 8 周远程医疗运动干预是可行的。我们的发现为减少 HCT 幸存者和其他高危癌症幸存者衰弱的监督运动干预的创新提供了依据。
试验注册:该方案和知情同意书获得了机构 IRB(IRB#20731)的批准,并在 ClinicalTrials.gov 上注册(NCT04968119;注册日期:2021 年 7 月 20 日)。
Mult Scler. 2016-10
Health Promot Chronic Dis Prev Can. 2022-6
Physiother Theory Pract. 2020-9
Blood Adv. 2024-9-24
Cancers (Basel). 2023-8-15
Laryngoscope. 2022-5
J Am Assoc Nurse Pract. 2021-6-7